Detalhe da pesquisa
1.
First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results.
Blood
; 139(26): 3699-3707, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421219
2.
Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.
Am J Hematol
; 98(8): 1246-1253, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246953
3.
Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up.
Blood Adv
; 7(19): 5890-5897, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459203
4.
Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B.
Blood Adv
; 5(13): 2732-2739, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242387
5.
Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone.
Am J Clin Dermatol
; 8(2): 93-102, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17428114
6.
Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized open-label trial.
Hum Vaccin Immunother
; 10(5): 1343-53, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24576885
7.
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
Vaccine
; 31(35): 3577-84, 2013 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23688526
8.
Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.
Clin Vaccine Immunol
; 19(8): 1296-303, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22739693